Sponsored Education Lunch Hub: Proteomics International Laboratories - Estimating the risk for kidney disease in diabetes
Tracks
Stream 1
Stream 2
Stream 3
Stream 4
| Wednesday, August 23, 2023 |
| 12:20 PM - 1:05 PM |
| Exhibition Hall - Education Hub 2 |
Details
Standard of Care for diagnosing CKD in T2D and its limitations
Identification of biomarkers associated with CKD, and the development of PromarkerD, a diagnostic test to predict future CKD in T2D (7-8 mins)
Close with a hypothetical case of a patient who has normal eGFR/uACR and what the doctors need to do to assess early/residual risk (5mins)
Speaker
Merlin Thomas
Introduce the clinical panel
Biography
Prof Karin Jandeleit-Dahm
Deputy Head
Department of Diabetes, Monash University
Burden of CKD on clinical care in patients with T2D
Biography
Prof Richard MacIsaac
Director of the Department of Endocrinology & Diabetes
St Vincent’s Hospital Melbourne / University of Melbourne
Standard of Care for diagnosing CKD in T2D and its limitations
Biography
Dr Kirsten Peters
Head Of Clinical Studies / Senior Biostatistician
Proteomics International Laboratories
Identification of biomarkers associated with CKD, and the development of PromarkerD, a diagnostic test to predict future CKD in T2D
Biography
Merlin Thomas
Close with a hypothetical case of a patient who has normal eGFR/uACR and what the doctors need to do to assess early/residual risk
Biography
